Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Operating Income (2021 - 2025)

Historic Operating Income for Dare Bioscience (DARE) over the last 5 years, with Q3 2025 value amounting to -$3.7 million.

  • Dare Bioscience's Operating Income rose 2155.79% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year increase of 2481.41%. This contributed to the annual value of -$23.5 million for FY2024, which is 2420.31% up from last year.
  • Dare Bioscience's Operating Income amounted to -$3.7 million in Q3 2025, which was up 2155.79% from -$3.8 million recorded in Q2 2025.
  • Dare Bioscience's Operating Income's 5-year high stood at $384322.0 during Q2 2022, with a 5-year trough of -$16.2 million in Q4 2022.
  • In the last 5 years, Dare Bioscience's Operating Income had a median value of -$7.1 million in 2022 and averaged -$7.1 million.
  • As far as peak fluctuations go, Dare Bioscience's Operating Income skyrocketed by 10419.43% in 2022, and later plummeted by 243901.68% in 2023.
  • Quarter analysis of 5 years shows Dare Bioscience's Operating Income stood at -$9.5 million in 2021, then plummeted by 70.08% to -$16.2 million in 2022, then soared by 68.14% to -$5.2 million in 2023, then dropped by 4.19% to -$5.4 million in 2024, then surged by 31.85% to -$3.7 million in 2025.
  • Its Operating Income stands at -$3.7 million for Q3 2025, versus -$3.8 million for Q2 2025 and -$4.6 million for Q1 2025.